ORKA
ORUKA THERA (ORKA)
NASDAQ
$104.40+$1.97 (+1.93%)
Price as of Aug 24, 2026 7:30 PM EDT
  • $7.1B
    Market Cap
  • 605.86%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
0
N/A
0
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-100.6M
+34.08%
-75.1M
+7,309.67%
-1.0M
-78.67%
-4.7M
-65.67%
Depreciation and Amortization Expense
83,000
+207.41%
27,000
+80.00%
15,000
-25.00%
20,000
+25.00%
Total Operating Expenses
122.1M
+38.50%
88.1M
+1,107.83%
7.3M
-31.14%
10.6M
-45.20%
Operating Profit
-122.1M
+38.50%
-88.1M
+1,107.83%
-7.3M
-31.14%
-10.6M
-45.20%
Interest Income
16.6M
+183.64%
5.9M
+199.59%
2.0M
+189.93%
675,000
+5,092.31%
Interest Expense
N/A
N/A
-1.5M
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
16.6M
+281.16%
4.4M
+122.94%
2.0M
+189.93%
675,000
+16,775.00%
Total Nonoperating Income and Expense
16.6M
+277.77%
4.4M
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-122.1M
+38.50%
-88.1M
+1,107.83%
-7.3M
-31.14%
-10.6M
-45.16%
Income Taxes
N/A
N/A
N/A
N/A
0
N/A
0
+100.00%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-105.4M
+25.93%
-83.7M
+1,468.16%
-5.3M
-46.21%
-9.9M
-48.63%
Net Income from Continuing Operations Applicable to Common
-105.4M
+25.93%
-83.7M
+1,468.16%
-5.3M
-46.21%
-9.9M
-48.63%
Basic EPS and Net Income
-1.85
-52.20%
-3.87
+945.95%
-0.37
-46.38%
-0.69
-50.36%
Diluted EPS and Net Income
-1.85
-52.20%
-3.87
+945.95%
-0.37
-46.38%
-0.69
-50.36%
Basic Weighted Average Shares
45.6M
+171.68%
16.8M
+16.46%
14.4M
+0.04%
14.4M
+3.64%
Diluted Weighted Average Shares
45.6M
+171.68%
16.8M
+16.46%
14.4M
+0.04%
14.4M
+3.64%
Balance Sheet
Cash and Cash Equivalents
46.9M
-23.78%
61.6M
+64.50%
37.4M
-11.81%
42.4M
-20.45%
Short-Term Investments
290.1M
-7.63%
314.1M
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
337.0M
-10.28%
375.6M
+903.57%
37.4M
-11.81%
42.4M
-20.45%
Total Current Assets
343.9M
-8.76%
376.9M
+902.52%
37.6M
-11.96%
42.7M
-21.54%
Accumulated Depreciation
N/A
N/A
N/A
N/A
212,000
+3.92%
204,000
+4.62%
Property and Plant and Equipment and Net
288,000
+77.78%
162,000
+1,520.00%
10,000
-60.00%
25,000
-47.92%
Total Long-Term Assets
103,000
+139.53%
43,000
+258.33%
12,000
-33.33%
18,000
0.00%
Total Assets
488.6M
+23.38%
396.0M
+945.98%
37.9M
-12.12%
43.1M
-21.56%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
15.4M
+17.87%
13.0M
+1,947.57%
637,000
-43.73%
1.1M
-67.64%
Total Long-Term Debt
N/A
N/A
N/A
N/A
0
N/A
0
N/A
Total Long-Term Liabilities
1.3M
+73.91%
755,000
+270.10%
204,000
-27.14%
280,000
-26.89%
Total Liabilities
16.7M
+20.94%
13.8M
+1,540.67%
841,000
-40.44%
1.4M
-63.62%
Retained Earnings
-189.2M
+125.93%
-83.7M
-55.64%
-188.7M
+2.91%
-183.4M
+5.72%
Total Stockholders Equity
471.9M
+23.47%
382.2M
+932.47%
37.0M
-11.17%
41.7M
-18.36%
Total Shares Outstanding
48.7M
+30.13%
37.4M
+158.19%
14.5M
+0.63%
14.4M
0.00%
Cash Flow
Cash from Operating Activities
-88.2M
+52.51%
-57.8M
+1,053.51%
-5.0M
-54.05%
-10.9M
-41.84%
Capital Expenditures
209,000
+10.58%
189,000
N/A
0
-100.00%
2,000
-95.35%
Cash from Investing Activities
-96.7M
-70.69%
-330.1M
N/A
0
+100.00%
-2,000
-95.35%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
170.3M
-62.11%
449.5M
N/A
0
-100.00%
23.1M
0.00%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-23.84%
-38.24%
-38.59%
+192.56%
-13.19%
-34.87%
-20.26%
-44.78%
Return on Equity
-24.69%
-38.19%
-39.94%
+194.35%
-13.57%
-36.63%
-21.41%
-45.94%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
22.37
-22.59%
28.89
-51.04%
59.01
+56.45%
37.72
+142.45%
Cash Ratio
3.05
-35.33%
4.72
-91.97%
58.76
+56.72%
37.50
+145.81%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow